Recent Quotes (30 days)

You have no recent quotes
chg | %

Covalon Technologies Ltd  

(Public, CVE:COV)   Watch this stock  
Find more results for covalon
-0.09 (-4.76%)
Oct 21 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.78 - 1.80
52 week 0.70 - 2.85
Open 1.80
Vol / Avg. 3,150.00/5,585.00
Mkt cap 35.24M
P/E     -
Div/yield     -
EPS -0.18
Shares 19.37M
Beta -1.28
Inst. own     -
Aug 22, 2016
Q3 2016 Covalon Technologies Ltd Earnings Call
Aug 19, 2016
Q3 2016 Covalon Technologies Ltd Earnings Release

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -6.03% -12.41%
Operating margin -4.77% -9.99%
EBITD margin - -6.81%
Return on average assets -8.00% -12.08%
Return on average equity -13.64% -18.27%
CDP Score - -


1660 Tech Ave Unit 5
+1-905-5688400 (Phone)
+1-905-5685200 (Fax)

Website links


Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care, infection management and surgical procedures. The Company's wound care dressing products include ColActive Plus, ColActive Transfer, CovaWound Silicone, CovaWound Silicone Sacrum, CovaWound Foam, CovaWound Alginate, CovaWound Super Absorbent and CovaWound Hydrocolloid. The Company's surgical and peri-operative products include SurgiClear, MediClear Post-Op Absorb and MediClear Scar. The Company's infection management products include IV Clear and SilverCoat Foley Catheter. The Company distributes products under the Covalon brand name. The Company also develops and commercializes medical products for other medical companies under development and license contracts. The Company's platform technologies include Collagen matrix, Antimicrobial silicone adhesive and Medical coating technology.

Officers and directors

Abe Schwartz Chairman of the Board
Brian E. Pedlar President, Chief Executive Officer, Director
Danny Brannagan Chief Financial Officer
Valerio DiTizio Chief Scientific Officer
Kim Crooks Vice President - Operations
John Hands Senior Director - Global Marketing
Elinor Caplan Director
Martin C. Bernholtz Independent Director
Ian Brindle Independent Director
Joseph Cordiano Independent Director